Prior Auth Required

0153U - negative breast cancer clinical subtype(s) with information on immune cell involvement

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicenegative breast cancer clinical subtype(s) with information on immune cell involvement
Procedure / Service Description

hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to - Oncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triple 0153U negative breast cancer clinical subtype(s) with information on immune cell involvement Oncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G],

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.